- Type / Class
- Equity / Common Stock
- Shares outstanding
- 82,773,190
- Total 13F shares
- 62,806,728
- Share change
- +9,916,158
- Total reported value
- $516,820,804
- Put/Call ratio
- 74%
- Price per share
- $8.23
- Number of holders
- 234
- Value change
- +$83,105,555
- Number of buys
- 113
- Number of sells
- 86
Quarterly Holders Quick Answers
What is CUSIP 28106W103?
CUSIP 28106W103 identifies EDIT - Editas Medicine, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28106W103:
Top shareholders of EDIT - Editas Medicine, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| STATE STREET CORP |
13F
|
Company |
9.9%
|
8,164,191
|
$59,190,385 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9%
|
7,418,362
|
$53,783,126 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.7%
|
7,202,714
|
$52,219,677 | — | 31 Mar 2023 | |
| Woodline Partners LP |
13F
|
Company |
3.2%
|
2,646,620
|
$19,187,995 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2%
|
1,622,819
|
$11,765,438 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
1,611,753
|
$11,684,443 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,451,254
|
$10,521,596 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.6%
|
1,283,937
|
$9,309,000 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.4%
|
1,132,951
|
$8,214,000 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.3%
|
1,056,973
|
$7,663,054 | — | 31 Mar 2023 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.3%
|
1,040,794
|
$7,545,757 | — | 31 Mar 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.2%
|
977,963
|
$7,090,232 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
941,895
|
$6,828,737 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.1%
|
901,000
|
$6,532,250 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
876,437
|
$6,354,170 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.86%
|
708,909
|
$5,139,590 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.85%
|
706,056
|
$5,118,907 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.83%
|
684,352
|
$4,961,552 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
669,629
|
$4,854,811 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.76%
|
632,471
|
$4,585,415 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
513,350
|
$3,721,788 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.6%
|
498,790
|
$3,616,228 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.6%
|
497,864
|
$3,609,515 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.58%
|
482,966
|
$3,502,000 | — | 31 Mar 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.53%
|
441,631
|
$3,201,825 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.51%
|
419,088
|
$3,038,385 | — | 31 Mar 2023 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.38%
|
317,877
|
$2,304,608 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.33%
|
275,122
|
$1,994,635 | — | 31 Mar 2023 | |
| STATE OF MICHIGAN RETIREMENT SYSTEM |
13F
|
Company |
0.33%
|
273,721
|
$1,984,477 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.32%
|
266,799
|
$1,934,293 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.32%
|
263,667
|
$1,911,587 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.31%
|
254,438
|
$1,844,676 | — | 31 Mar 2023 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.29%
|
239,466
|
$1,736,128 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.28%
|
227,800
|
$1,651,550 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.26%
|
215,136
|
$1,559,737 | — | 31 Mar 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
214,309
|
$1,553,740 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.24%
|
202,339
|
$1,466,958 | — | 31 Mar 2023 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.24%
|
195,502
|
$1,417,390 | — | 31 Mar 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.21%
|
170,121
|
$1,233,375 | — | 31 Mar 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.2%
|
167,981
|
$1,217,862 | — | 31 Mar 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.2%
|
166,782
|
$1,209,170 | — | 31 Mar 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.2%
|
161,600
|
$1,171,600 | — | 31 Mar 2023 | |
| Michelle Robertson |
3/4/5
|
EVP, CHIEF FINANCIAL OFFICER |
—
class O/S missing
|
106,610
|
$1,161,750 | — | 11 May 2023 | |
| Edgestream Partners, L.P. |
13F
|
Company |
0.19%
|
154,789
|
$1,122,220 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
148,400
|
$1,075,900 | — | 31 Mar 2023 | |
| Jump Financial, LLC |
13F
|
Company |
0.17%
|
143,651
|
$1,041,470 | — | 31 Mar 2023 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.17%
|
142,318
|
$1,031,817 | — | 31 Mar 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
0.17%
|
140,000
|
$1,015,000 | — | 31 Mar 2023 | |
| PROFUND ADVISORS LLC |
13F
|
Company |
0.15%
|
125,742
|
$911,630 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.14%
|
114,269
|
$828,450 | — | 31 Mar 2023 |
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2023
As of 30 Jun 2023,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
234 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,806,728 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Deep Track Capital, LP, Avidity Partners Management LP, MARSHALL WACE, LLP, Woodline Partners LP, DIMENSIONAL FUND ADVISORS LP, MORGAN STANLEY, and PICTET ASSET MANAGEMENT SA.
This page lists
234
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
231
Q2 2023 holders
234
Holder diff
3
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.